235 related articles for article (PubMed ID: 7527767)
1. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E
Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
[TBL] [Abstract][Full Text] [Related]
2. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E
J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
[TBL] [Abstract][Full Text] [Related]
3. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism.
Rossini PM; Bassetti MA; Pasqualetti P
Electroencephalogr Clin Neurophysiol; 1995 May; 96(3):236-47. PubMed ID: 7750449
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components.
Rossini PM; Traversa R; Boccasena P; Martino G; Passarelli F; Pacifici L; Bernardi G; Stanzione P
Neurology; 1993 Dec; 43(12):2495-500. PubMed ID: 8255446
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
Mauguière F; Broussolle E; Isnard J
Electroencephalogr Clin Neurophysiol; 1993; 88(4):243-54. PubMed ID: 7688279
[TBL] [Abstract][Full Text] [Related]
6. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
Pierantozzi M; Mazzone P; Bassi A; Rossini PM; Peppe A; Altibrandi MG; Stefani A; Bernardi G; Stanzione P
Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
[TBL] [Abstract][Full Text] [Related]
7. Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes.
Pierantozzi M; Sabato AF; Leonardis F; Marciani MG; Cicardi C; Giacomini P; Bernardi G; Stanzione P
Exp Brain Res; 2000 Aug; 133(3):368-76. PubMed ID: 10958527
[TBL] [Abstract][Full Text] [Related]
8. [Somatosensory evoked potentials and symptomatic response to dopaminergic drugs in Parkinson's disease].
Castillo JL; Miranda CM; Araya F; Sáez D
Rev Med Chil; 1996 Mar; 124(3):301-6. PubMed ID: 9008941
[TBL] [Abstract][Full Text] [Related]
9. Somatosensory input to non-primary motor areas is enhanced during preparation of cued contraterlateral finger sequence movements.
Brown MJ; Staines WR
Behav Brain Res; 2015 Jun; 286():166-74. PubMed ID: 25746454
[TBL] [Abstract][Full Text] [Related]
10. The selective gating of the N30 cortical component of the somatosensory evoked potentials of median nerve is different in the mesial and dorsolateral frontal cortex: evidence from intracerebral recordings.
Kanovský P; Bares M; Rektor I
Clin Neurophysiol; 2003 Jun; 114(6):981-91. PubMed ID: 12804666
[TBL] [Abstract][Full Text] [Related]
11. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD.
Ulivelli M; Rossi S; Pasqualetti P; Rossini PM; Ghiglieri O; Passero S; Battistini N
Neurology; 1999 Oct; 53(7):1451-7. PubMed ID: 10534250
[TBL] [Abstract][Full Text] [Related]
12. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P
J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624
[TBL] [Abstract][Full Text] [Related]
13. Lateralization of the P22/N30 precentral cortical component of the median nerve somatosensory evoked potentials is different in patients with a tonic or tremulous form of cervical dystonia.
Kañovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1999 Jul; 14(4):642-51. PubMed ID: 10435502
[TBL] [Abstract][Full Text] [Related]
14. N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease.
Drory VE; Inzelberg R; Groozman GB; Korczyn AD
Acta Neurol Scand; 1998 Feb; 97(2):73-6. PubMed ID: 9517855
[TBL] [Abstract][Full Text] [Related]
15. Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.
Bostantjopoulou S; Katsarou Z; Zafiriou D; Gerasimou G; Alevriadou A; Georgiadis G; Kiosseoglou G; Kazis A
Neurophysiol Clin; 2000 Dec; 30(6):368-76. PubMed ID: 11191929
[TBL] [Abstract][Full Text] [Related]
16. Abnormal premovement gating of somatosensory input in writer's cramp.
Murase N; Kaji R; Shimazu H; Katayama-Hirota M; Ikeda A; Kohara N; Kimura J; Shibasaki H; Rothwell JC
Brain; 2000 Sep; 123 ( Pt 9)():1813-29. PubMed ID: 10960045
[TBL] [Abstract][Full Text] [Related]
17. SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status.
Stanzione P; Traversa R; Pierantozzi M; Semprini R; Loberti M; Peppe A; Santilli AM; Bernardi G
Eur J Neurol; 1997 Jan; 4(1):24-38. PubMed ID: 24283819
[TBL] [Abstract][Full Text] [Related]
18. Astereognosis and dissociated loss of frontal or parietal components of somatosensory evoked potentials in hemispheric lesions. Detailed correlations with clinical signs and computerized tomographic scanning.
Mauguière F; Desmedt JE; Courjon J
Brain; 1983 Jun; 106 (Pt 2)():271-311. PubMed ID: 6850271
[TBL] [Abstract][Full Text] [Related]
19. Non-dominant hand movement facilitates the frontal N30 somatosensory evoked potential.
Legon W; Dionne JK; Meehan SK; Staines WR
BMC Neurosci; 2010 Sep; 11():112. PubMed ID: 20822535
[TBL] [Abstract][Full Text] [Related]
20. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease.
Garcia PA; Aminoff MJ; Goodin DS
Neurology; 1995 May; 45(5):989-92. PubMed ID: 7746421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
